Gene · 3161
Papers2,270
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,270
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A human transcriptomic deletion links cortical expansion and cancer. | bioRxiv | 2026 | 42779997 | PubTator, text mining | PubMed |
| RHAMM drives formation of polyploid cancer cells and confers resistance to ER-targeted therapy in breast cancer. | Proc Natl Acad Sci U S A | 2026 | 42748147 | PubTator, text mining | PubMed |
| Hmmr+ Fibroblasts Facilitate Hair Regeneration by Biomechanical Sensing of Extracellular Matrix Viscoelasticity. | Research (Wash D C) | 2026 | 42741478 | PubTator, text mining | PubMed |
| A model of cellular proliferation and mitochondrial biogenesis predicts prognosis and immunotherapy response in lung adenocarcinoma. | Transl Cancer Res | 2026 | 42724831 | PubTator, text mining | PubMed |
| HMMR+ stromal cells drive human uterine development. | Cell Discov | 2026 | 42706229 | PubTator, text mining | PubMed |
| Regulation of TMEM2-mediated hyaluronan degradation by CD44 and LYVE-1. | Front Mol Biosci | 2026 | 42656528 | PubTator, text mining | PubMed |
| Screening of Metabolic Reprogramming-Related Diagnostic Biomarkers and Analysis of Immune Heterogeneity in Atopic Dermatitis Based on Multi-Cohort Validation. | Clin Cosmet Investig Dermatol | 2026 | 42605368 | PubTator, text mining | PubMed |
| MicroRNA Signatures of Fulvestrant-Treated Luminal Breast Cancer Cells: Identification of Therapeutic Targets Regulated by miR-374b-5p. | Int J Mol Sci | 2026 | 42589442 | PubTator, text mining | PubMed |
| An oxidative stress - and immunotherapy-related six-gene signature defines immune subtypes and predicts prognosis and immunotherapy response in hepatocellular carcinoma. | Gene | 2026 | 42551718 | PubTator, text mining | PubMed |
| Identification of telomere-related gene signatures for immune cell infiltration and prognosis in hepatocellular carcinoma. | Transl Cancer Res | 2026 | 42445403 | PubTator, text mining | PubMed |
| The myofascial rheostat: hyaluronan molecular weight dynamics and purinergic signalling as a physiological feedback system. | Front Physiol | 2026 | 42389755 | PubTator, text mining | PubMed |
| Hyaluronan Signaling Ameliorates the Epithelial Injury Response and Barrier Disruption After Ozone Exposure. | Biomolecules | 2026 | 42352262 | PubTator, text mining | PubMed |
| Identification of circadian rhythm-associated key genes in metabolic dysfunction-associated fatty liver disease. | Clin Exp Med | 2026 | 42329455 | PubTator, text mining | PubMed |
HMMR as a robust prognostic biomarker correlates with immune infiltration and cell cycle pathways in oral squamous cell carcinoma: a multi-cohort bioinformatics analysis based on TCGA and GEO databases. | Front Genet | 2026 | 42326385 | PubTator, text mining | PubMed |
| PDIA1 promotes androgen receptor activation and prostate cancer cell survival through enhancing HMMR stability. | FEBS Lett | 2026 | 42290188 | PubTator, text mining | PubMed |
| Hyaluronic Acid-Based Biomaterials in Tissue Engineering: From Molecular Properties to Re-Generative Applications. | J Funct Biomater | 2026 | 42188413 | PubTator, text mining | PubMed |
Mechanism analysis of transgene expression induced by chitosan/hyaluronic acid nanoparticles in CD44v9/RHAMM co-expressed gastric cancer cells: contribution of hyaluronic acid to RHAMM-mediated intracellular transport. | Glycoconj J | 2026 | 42142272 | PubTator, text mining | PubMed |
| ASPM promotes the progression of esophageal squamous cell carcinoma by upregulating the expression of HMMR. | Cancer Cell Int | 2026 | 42021279 | PubTator, text mining | PubMed |
| Deoxyshikonin inhibits the proliferation, invasion, and tumor immune microenvironment in breast cancer cells by inactivating the PI3K/AKT/NF-κB pathway. | Nutr Res Pract | 2026 | 41970322 | PubTator, text mining | PubMed |
| Hyaluronic acid: emerging roles and biomaterial innovations in Alzheimer's and Parkinson's disease therapy. | Front Pharmacol | 2026 | 41948730 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3161/papers